Bill C-13, the COVID-19 Emergency Response Act, was the Canadian government’s legislative response to the Coronavirus pandemic. In addition a host of economic measures, the bill included some unexpected patent law provisions designed to speed access to essential medicines, devices or treatments. Matthew Herder, the director of the Health Law Institute at Dalhousie University, joins the podcast discuss the new Canadian rules, the use of compulsory licensing to enhance access to medicines, and other innovative approaches to overcoming potential access barriers raised by intellectual property laws.
Recent Posts
The Data on Australia’s Social Media Ban: The Better the Privacy Protection, The Less Effective the Ban 
Shaky Ground Gets Shakier: What the U.S. Supreme Court’s Location Data Decision Means for Bill C-22 
The Two Weeks That Reshaped Canada’s Digital Policy 
The Law Bytes Podcast, Episode 274: Mark Musselman on What Stakeholders Really Think About the Government’s Reversal of the CRTC Online Streaming Act Decision 
Improv Policy: The Government Doesn’t Know What To Do About Its Online Streaming Act Mess
